Anthropometry (2)
- height - Subject's height (phv00265982.v1.p1)
- weight - Subject's weight (phv00265983.v1.p1)
Biomarkers (4)
- ecg_pr_int - ECG - PR Interval (phv00265988.v1.p1)
- ecg_qrs_int - ECG - QRS Interval (phv00265989.v1.p1)
- ecg_qt_int - ECG - QT Interval (phv00265990.v1.p1)
- ecg_ventricular_rate - ECG - Ventricular Rate (phv00265991.v1.p1)
Demographics (3)
- age_diagnosis - Age at AF diagnosis (phv00265978.v1.p1)
- sex - Gender of participant (phv00265979.v1.p1)
- SEX - Reported Sex of Subject (phv00530114.v1.p1)
Disease Events (2)
- diabetes - Diabetes at enrollment (phv00265985.v1.p1)
- myocardial_infarction - Myocardial infarction at enrollment (phv00265987.v1.p1)
Race and Ethnicity (2)
- ethnicity - Ethnicity of participant (phv00265981.v1.p1)
- race - Race of participant (phv00265980.v1.p1)
Study Administration (1)
- CONSENT - Consent group as determined by DAC (phv00253774.v2.p1)
Other (18)
- af_status - AF status (phv00265977.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00253781.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00253780.v1.p1)
- Funding_Source - Funding Source (phv00318339.v1.p1)
- heart_failure - Heart failure at enrollment (phv00265986.v1.p1)
- hypertension - Hypertension at enrollment (phv00265984.v1.p1)
- IS_TUMOR - Tumor status (phv00253782.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00253779.v1.p1)
- SAMPLE_ID - Sample ID (phv00253777.v1.p1)
- SEQUENCING_CENTER - SEQUENCING CENTER (phv00318338.v1.p1)
- SOURCE_SUBJECT_ID - Source Subject ID (phv00318337.v2.p1)
- Study_Name - Study Name (phv00318342.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00265976.v1.p1)
- SUBJECT_ID - Subject ID (phv00253773.v2.p1)
- SUBJECT_ID - Subject ID (phv00253776.v1.p1)
- SUBJECT_SOURCE - Subject Source (phv00318336.v2.p1)
- TOPMed_Phase - TOPMed Phase (phv00318340.v1.p1)
- TOPMed_Project - TOPMed Project (phv00318341.v1.p1)